newsfilter
← Latest News
GlobeNewswire·

REPEAT -- Celyad Oncology SA - Letter to Shareholders

MONT-SAINT-GUIBERT, Belgium, March 01, 2023 (GLOBE NEWSWIRE) -- The following is a statement by Celyad Oncology: Dear Shareholder, 2022 has been a crossroad year for Celyad Oncology (the "Company"), with important